Biology of ALS study
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study explores the molecular biology of ALS to better understand the disease and find potential new treatments. It may help identify key patterns that could lead to personalized care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a patient of Dr. Espíndola at UFSC.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to match people with ALS to potential treatments based on their genetic profile. It connects you to a network of trials that may be relevant to your specific type of ALS.
This study looks at genetic risk for amyotrophic lateral sclerosis (ALS) in families. It may help researchers understand who carries ALS-related gene changes and how that affects future care.
This study collects and stores medical information from people diagnosed with ALS or certain related conditions affecting movement. It may help researchers better understand how these illnesses change over time and improve future treatments.
This study looks for biological markers in the blood or other samples to track how ALS progresses over time. The goal is to catch changes earlier, which could help in future treatments.
This study follows people living with amyotrophic lateral sclerosis (ALS) over time. It may help researchers better understand ALS and track changes that could guide future treatments.
This study watches people with ALS over time to better understand how symptoms change and what features show up. It may help future care and treatments by improving doctors’ understanding of ALS’s natural course.
Hear when a new ALS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.